Notably, Liu et al. reported that IL-6 increased the expression of DNMT1 but not DNMT3a and DNMT3b and enriched the lung cancer stem-like cell population by inhibiting the cell cycle regulator [34]. The gene discussed is IL6; the disease is lung carcinoma.